Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schenkein

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bone Marrow Transplantation|February 23, 2002
Should involved-field radiation therapy be used as an adjunct to lymphoma autotransplantation?P Wadhwa, D C Shina, D Schenkein, et al.
American Journal of Ophthalmology|November 13, 2001
Lens changes in hereditary hyperferritinemia-cataract syndromeA Chang-Godinich, S Ades, D Schenkein, et al.
Bone Marrow Transplantation|September 14, 1999
Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysisR Kanteti, K Miller, J McCann, et al.
Annals of Internal Medicine|November 30, 1999
Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancerJ A DesJardin, M E Falagas, R Ruthazer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 5, 2006
An electrodiagnostic evaluation of the effect of pre-existing peripheral nervous system disorders in patients treated with the novel proteasome inhibitor bortezomibM D Stubblefield, S Slovin, B MacGregor-Cortelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphomaJ M Vose, M Crump, H Lazarus, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemiaS P Treon, T B Agus, B Link, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bone Marrow Transplantation|February 23, 2002
Should involved-field radiation therapy be used as an adjunct to lymphoma autotransplantation?P Wadhwa, D C Shina, D Schenkein, et al.
American Journal of Ophthalmology|November 13, 2001
Lens changes in hereditary hyperferritinemia-cataract syndromeA Chang-Godinich, S Ades, D Schenkein, et al.
Bone Marrow Transplantation|September 14, 1999
Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysisR Kanteti, K Miller, J McCann, et al.
Annals of Internal Medicine|November 30, 1999
Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancerJ A DesJardin, M E Falagas, R Ruthazer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 5, 2006
An electrodiagnostic evaluation of the effect of pre-existing peripheral nervous system disorders in patients treated with the novel proteasome inhibitor bortezomibM D Stubblefield, S Slovin, B MacGregor-Cortelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphomaJ M Vose, M Crump, H Lazarus, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemiaS P Treon, T B Agus, B Link, et al.
Pageof 1